Table 3.
Associations between Medication Adherence, and demographic data, disease type, PRAQ score, scores of TMG, BMQ, CQR-19 and PedsQLTM-SSS questionnaires.
| Medication adherent |
|||
|---|---|---|---|
| Adherent (N = 47) | Non-adherent (N = 3) | p value | |
| Gender, n (%) | 1.000 | ||
| Female | 28 (59.6) | 2 (66.7) | |
| Male | 19 (40.4) | 1 (33.3) | |
| Age (years) | 0.526 | ||
| Mean ± SD | 10.1 ± 5.3 | 12.3 ± 3.1 | |
| Median (minimum - maximum) | 11.0 (1.0 – 18.0) | 13.0 (9.0 – 15.0) | |
| Disease, n (%) | 0.757 | ||
| JSLE | 21 (44.7) | 1 (33.3) | |
| JIA | 19 (40.4) | 2 (66.7) | |
| JDM | 5 (10.6) | 0 (0.0) | |
| JSSc | 1 (2.1) | 0 (0.0) | |
| TAK | 1 (2.1) | 0 (0.0) | |
| PRAQ 1st evaluation | 0.491 | ||
| Mean ± SD | 5.3 ± 1.8 | 5.7 ± 1.2 | |
| Median (minimum - maximum) | 5.0 (2.0 – 11.0) | 5.0 (5.0 – 7.0) | |
| TMG 2nd evaluation - classification, n (%) | 0.005 | ||
| High | 35 (74.5) | 0 (0.0) | |
| Medium | 12 (25.5) | 2 (66.7) | |
| Low | 0 (0.0) | 1 (33.3) | |
| BMQ 2nd evaluation - classification, n (%) | 0.048 | ||
| Adherent | 42 (89.4) | 1 (33.3) | |
| Non-adherent | 5 (10.6) | 2 (66.7) | |
| CQR-19 2nd evaluation-classification, n (%) | 0.035 | ||
| Adherent | 43 (91.5) | 1 (33.3) | |
| Non-adherent | 4 (8.5) | 2 (66.7) | |
| PedsQLTM-SSS 2nd evaluation | 0.246 | ||
| Mean ± SD | 96.0 ± 4.4 | 94.2 ± 3.9 | |
| Median (minimum - maximum) | 97.0 (83.0 –100.0) | 95.8 (89.7 – 97.0) | |
p – descriptive level of Fisher's exact test or Mann-Whitney test. n total = 50.
JSLE, Juvenile Systemic Lupus Erythematosus; JIA, Juvenile Idiopathic Arthritis; JDM, Juvenile Dermatomyositis; JSSc, Juvenile Systemic Sclerosis; TAK, Takayasu's Arteritis; MGT, Morisky Green test; BMQ, Brief Medication Questionnaire; CQR-19, Compliance Questionnaire; PRAQ, Pediatric Rheumatology Adherence Questionnaire; PedsQL-SSS, Pediatric Quality of Life Inventory version 3.0.